Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Patiënten met CVT hebben verhoogd risico op kanker
feb 2025 | Benigne hematologie, Neuro-vasculair